Literature DB >> 19652319

Polymorphism and phase transition behavior of 6,6'-bis(chloromethyl)-1,1',4,4'-tetramethyl-3,3'-(p-phenylenedimethylene)bis(piperazine-2,5-dione).

Nathan W Polaske1, Gary S Nichol, Bogdan Olenyuk.   

Abstract

A crystallographic investigation of the title compound, C22H28Cl2N4O4, using crystals obtained under different crystallization conditions, revealed the presence of two distinct polymorphic forms. The molecular conformation in the two polymorphs is very different: one adopts a 'C' shape, whereas the other adopts an 'S' shape. In the latter, the molecule lies across a crystallographic twofold axis. The 'S'-shaped polymorph undergoes a reversible orthorhombic-to-monoclinic phase transition on cooling, whereas the structure of the 'C'-shaped polymorph is temperature insensitive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652319      PMCID: PMC2720150          DOI: 10.1107/S0108270109024457

Source DB:  PubMed          Journal:  Acta Crystallogr C        ISSN: 0108-2701            Impact factor:   1.172


  13 in total

1.  The Cambridge Structural Database: a quarter of a million crystal structures and rising.

Authors:  Frank H Allen
Journal:  Acta Crystallogr B       Date:  2002-05-29

2.  Chaetomin, a New Antibiotic Substance Produced by Chaetomium cochliodes: I. Formation and Properties.

Authors:  S A Waksman; E Bugie
Journal:  J Bacteriol       Date:  1944-11       Impact factor: 3.490

Review 3.  The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis.

Authors:  Donald M Gardiner; Paul Waring; Barbara J Howlett
Journal:  Microbiology       Date:  2005-04       Impact factor: 2.777

4.  WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. I. Fermentation and isolation.

Authors:  D M Sedlock; C J Barrow; J E Brownell; A Hong; A M Gillum; D R Houck
Journal:  J Antibiot (Tokyo)       Date:  1994-04       Impact factor: 2.649

5.  The structure of chetomin.

Authors:  A G McInnes; A Taylor; J A Walter
Journal:  J Am Chem Soc       Date:  1976-10-13       Impact factor: 15.419

6.  Chaetocochins A-C, epipolythiodioxopiperazines from Chaetomium cochliodes.

Authors:  Guo-You Li; Bo-Gang Li; Tao Yang; Ju-Fang Yan; Guang-Ye Liu; Guo-Lin Zhang
Journal:  J Nat Prod       Date:  2006-09       Impact factor: 4.050

7.  Molecular Solids from Symmetrical Bis(piperazine-2,5-diones) with Open and Closed Monomer Conformations.

Authors:  Nathan W Polaske; Gary S Nichol; Lajos Z Szabó; Bogdan Olenyuk
Journal:  Cryst Growth Des       Date:  2009-04-01       Impact factor: 4.076

8.  Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway.

Authors:  Andrew L Kung; Sonya D Zabludoff; Dennis S France; Steven J Freedman; Elizabeth A Tanner; Annelisa Vieira; Susan Cornell-Kennon; Jennifer Lee; Beqing Wang; Jamin Wang; Klaus Memmert; Hans-Ulrich Naegeli; Frank Petersen; Michael J Eck; Kenneth W Bair; Alexander W Wood; David M Livingston
Journal:  Cancer Cell       Date:  2004-07       Impact factor: 31.743

9.  WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. III. Biosynthetic analogs.

Authors:  J L Popp; L L Musza; C J Barrow; P J Rudewicz; D R Houck
Journal:  J Antibiot (Tokyo)       Date:  1994-04       Impact factor: 2.649

10.  WIN 64821, a novel neurokinin antagonist produced by an Aspergillus sp. II. Biological activity.

Authors:  J J Oleynek; D M Sedlock; C J Barrow; K C Appell; F Casiano; D Haycock; S J Ward; P Kaplita; A M Gillum
Journal:  J Antibiot (Tokyo)       Date:  1994-04       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.